Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers

This book PDF is perfect for those who love Electronic Books genre, written by Veysel Kayser and published by Mdpi AG which was released on 25 January 2022 with total hardcover pages 298. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers books below.

Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers
Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers
Author : Veysel Kayser
File Size : 43,6 Mb
Publisher : Mdpi AG
Language : English
Release Date : 25 January 2022
ISBN : 3036526870
Pages : 298 pages
Get Book

Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers by Veysel Kayser Book PDF Summary

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.

Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers

Therapeutic Monoclonal Antibodies and Antibody Products Their Optimization and Drug Design in Cancers by Veysel Kayser

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from

Get Book
Antibody Drug Conjugates and Immunotoxins

Antibody Drug Conjugates and Immunotoxins by Gail Lewis Phillips

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Get Book
Antibody Drug Conjugates

Antibody Drug Conjugates by Laurent Ducry

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters

Get Book
Macromolecular Anticancer Therapeutics

Macromolecular Anticancer Therapeutics by L. Harivardhan Reddy,Patrick Couvreur

In spite of the development of various anticancer drugs, the therapy of cancer has remained challenging for decades. The current therapy of cancer is overwhelmed because of the inability to deliver therapeutics to all regions of a tumor in effective therapeutic concentrations, intrinsic or acquired resistance to the treatment with

Get Book
Antibody Drug Conjugates

Antibody Drug Conjugates by Laurent Ducry

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters

Get Book
Antibody Drug Conjugates

Antibody Drug Conjugates by Kenneth J. Olivier, Jr.,Sara A. Hurvitz

Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells. • Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies • Covers the conduct and design

Get Book
Antibody Drug Conjugates and Immunotoxins

Antibody Drug Conjugates and Immunotoxins by Gail Lewis Phillips

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Get Book
Antibody Drug Discovery

Antibody Drug Discovery by Clive R. Wood

Antibody-based therapeutics are a central driver of the success of biopharmaceuticals. The discovery technology of this field is isolated to a limited number of centers of excellence in industry and academia. The objective of this volume is to provide a series of guides to those evaluating and preparing to enter

Get Book